Print

Novel Kinase Inhibitor Promising in NSCLC, Umea University Study  
10/28/2010 6:34:53 AM

MedPageToday -- Non-small cell lung cancers and other tumors with a mutation in anaplastic lymphoma kinase (ALK) respond dramatically to a novel agent that "switches off" the faulty gene, according to early trial results.
//-->